# Huarun Zhengda Life Science Fund

Huarun Zhengda Life Science Fund is a Fund based in Shanghai, China.

## Overview

- **Organization type:** Fund
- **Headquarters:** Shanghai, China
- **Region:** Asia
- **Address:** Shanghai, China
- **Assets under management:** Undisclosed

## Regulatory record

- **Reports private funds:** No

## About

Huarun Zhengda Life Science Fund was established as a joint investment platform between China Resources (Huarun) Group and Thailand's Charoen Pokphand Group (Zhengda). The fund focuses on life sciences, including pharmaceuticals, biotechnology, and healthcare services, across Asia. The fund deploys capital into direct investments and co-investments across the life sciences value chain — from early-stage biotech to established pharmaceutical firms. Geographic focus spans China and Southeast Asia, with offices in Shanghai, Shenzhen, Bangkok, and Hong Kong. Named portfolio companies or specific deal values have not been publicly disclosed. The fund's scale and team size remain undisclosed. Adjacent vehicles include the broader investment arms of Huarun Group and Charoen Pokphand Group, which operate across real estate, retail, finance, and other sectors. No recent operational events have been confirmed. A structural differentiator is the joint-venture model pairing a Chinese state-linked conglomerate with a Thai private business group, creating a rare cross-border life sciences investment platform. This architecture may provide portfolio companies with regulatory access and distribution channels across both markets.

## Sectors

- Life Sciences
- Pharmaceuticals
- Healthcare Services
- Biotech

## Offices

- Shenzhen
- Bangkok
- Hong Kong

## Questions

### What is the investment focus of Huarun Zhengda Life Science Fund?

The fund concentrates on life sciences, including pharmaceuticals, biotechnology, and healthcare services. It targets opportunities across the value chain from early-stage R&D to established manufacturing and distribution (public record).

### Who are the parent entities behind Huarun Zhengda Life Science Fund?

The fund is a joint venture between China Resources (Huarun) Group, a Chinese state-owned conglomerate, and Charoen Pokphand Group (Zhengda), a Thai private business group. Both groups have extensive operations in their respective home markets (public record).

### Is information about the fund's size or portfolio holdings available?

No AUM, investment size, or specific portfolio company names have been publicly disclosed. The fund's scale and track record remain opaque (public record).

## Related profiles

- [Ruiyou Capital](https://altss.com/profile/ruiyou-capital)
- [Relo Group](https://altss.com/profile/relo-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/huarun-zhengda-life-science-fund

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology